US Stock MarketDetailed Quotes
AFIB Acutus Medical
- 0.1685
- +0.0051+3.12%
Trading Apr 26 14:14 ET
5.01MMarket Cap-59P/E (TTM)
0.1690High0.1600Low204.64KVolume0.1659Open0.1634Pre Close33.48KTurnover0.87%Turnover RatioLossP/E (Static)29.72MShares1.089952wk High-5.62P/B3.95MFloat Cap0.160052wk Low--Dividend TTM23.43MShs Float38.9900Historical High--Div YieldTTM5.51%Amplitude0.1600Historical Low0.1630Avg Price1Lot Size
Acutus Medical Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 136.36%7.16M | 10.01%-7.53M | 43.74%5.24M | 29.76%5.29M | 13.28%4.17M | -82.44%3.03M | -291.88%-8.37M | -20.80%3.64M | -13.44%4.08M | 2.51%3.68M |
| Operating revenue | 136.36%7.16M | 10.01%-7.53M | 43.74%5.24M | 29.76%5.29M | 13.28%4.17M | -82.44%3.03M | -291.88%-8.37M | -20.80%3.64M | -13.44%4.08M | 2.51%3.68M |
| Cost of revenue | 108.48%10.3M | 29.50%-13.15M | 23.65%8.6M | -16.85%8.06M | -2.18%6.79M | -84.99%4.94M | -287.62%-18.65M | -18.60%6.95M | 29.43%9.7M | -0.20%6.94M |
| Gross profit | -64.24%-3.14M | -45.38%5.61M | -1.51%-3.36M | 50.65%-2.77M | 19.63%-2.62M | 87.80%-1.91M | 284.29%10.28M | 16.02%-3.31M | -101.98%-5.62M | 3.09%-3.26M |
| Operating expense | -25.11%17.55M | 27.86%-26.44M | -21.75%12.23M | -27.15%16.08M | -29.95%15.68M | -76.62%23.43M | -248.38%-36.66M | -37.76%15.63M | -10.89%22.08M | -12.62%22.39M |
| Selling and administrative expenses | -30.76%14.07M | 31.73%-12.21M | -23.22%7.43M | -34.36%9.28M | -33.51%9.57M | -68.02%20.32M | -212.78%-17.89M | -38.76%9.68M | -9.35%14.14M | -11.49%14.39M |
| Research and development costs | 11.67%3.48M | 24.17%-14.23M | -19.36%4.8M | -14.32%6.8M | -23.57%6.12M | -91.50%3.12M | -312.29%-18.77M | -36.06%5.95M | -13.51%7.94M | -14.59%8M |
| Operating profit | 18.38%-20.69M | -31.70%32.06M | 17.68%-15.58M | 31.92%-18.86M | 28.64%-18.3M | 78.13%-25.34M | 255.00%46.94M | 34.81%-18.93M | -0.51%-27.7M | 11.52%-25.65M |
| Net non-operating interest income expense | 28.36%-3.07M | -54.65%-1.18M | 0.69%-862K | 54.79%-571K | 67.27%-454K | 23.02%-4.28M | 44.06%-763K | 38.96%-868K | 11.49%-1.26M | -2.89%-1.39M |
| Non-operating interest income | 198.16%2.59M | -36.63%365K | 126.97%547K | 2,951.85%824K | 3,454.17%853K | 648.28%868K | 1,957.14%576K | 1,168.42%241K | -6.90%27K | -40.00%24K |
| Non-operating interest expense | 9.83%5.66M | 15.38%1.55M | 27.05%1.41M | 8.14%1.4M | -7.37%1.31M | -9.30%5.15M | -3.81%1.34M | -23.04%1.11M | -11.40%1.29M | 1.66%1.41M |
| Other net income (expense) | -79.66%11.89M | -86.40%5.09M | 625.44%3.28M | -96.88%1.08M | 118.80%2.44M | 1,460.92%58.47M | 9,690.31%37.4M | -132.00%-625K | 13,341.86%34.68M | -1,225.93%-12.98M |
| Gain on sale of security | 8,800.00%2.94M | 267.51%1.46M | -29.65%636K | ---604K | --1.45M | --33K | ---871K | --904K | ---- | ---- |
| Special income (charges) | -84.67%8.96M | -90.52%3.63M | 273.19%2.65M | -95.14%1.69M | 107.66%995K | 1,460.04%58.44M | 9,918.32%38.27M | -178.29%-1.53M | 13,341.86%34.68M | -1,225.93%-12.98M |
| -Less：Restructuring and merger&acquisition | -88.32%123K | 80.04%-475K | --0 | -59.28%386K | -77.82%212K | 128.11%1.05M | -523.04%-2.38M | 178.29%1.53M | 467.44%948K | 182.91%956K |
| -Less:Impairment of capital assets | --0 | --0 | --0 | --0 | --0 | --12.03M | --0 | --0 | --0 | --12.03M |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | --7.95M | --0 | ---- | --7.95M | ---- |
| -Gain on sale of business | -88.57%9.08M | -91.21%3.15M | --2.65M | -95.24%2.07M | --1.21M | --79.47M | --35.89M | --0 | --43.58M | --0 |
| Income before tax | -141.11%-11.86M | -56.97%35.97M | 35.56%-13.16M | -420.85%-18.35M | 59.23%-16.32M | 124.51%28.85M | 367.31%83.57M | 28.36%-20.43M | 119.90%5.72M | -37.13%-40.02M |
| Income tax | 320.00%63K | -180.00%-12K | 75K | 0 | 0 | 15K | 15K | 0 | 0 | 0 |
| Net income | -106.14%-81.66M | -323.49%-33.77M | 35.19%-13.24M | -420.85%-18.35M | 59.23%-16.32M | 66.34%-39.62M | 148.32%15.11M | 28.36%-20.43M | 119.90%5.72M | -37.13%-40.02M |
| Net income continuous Operations | -141.34%-11.92M | -56.94%35.98M | 35.19%-13.24M | -420.85%-18.35M | 59.23%-16.32M | 124.50%28.83M | 367.26%83.56M | 28.36%-20.43M | 119.90%5.72M | -37.13%-40.02M |
| Net income discontinuous operations | -1.89%-69.74M | ---- | ---- | ---- | ---- | ---68.45M | ---- | ---- | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -106.14%-81.66M | -323.49%-33.77M | 35.19%-13.24M | -420.85%-18.35M | 59.23%-16.32M | 66.34%-39.62M | 148.32%15.11M | 28.36%-20.43M | 119.90%5.72M | -37.13%-40.02M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -106.14%-81.66M | -323.49%-33.77M | 35.19%-13.24M | -420.85%-18.35M | 59.23%-16.32M | 66.34%-39.62M | 148.32%15.11M | 28.36%-20.43M | 119.90%5.72M | -37.13%-40.02M |
| Basic earnings per share | -100.71%-2.81 | -318.87%-1.16 | 37.50%-0.45 | -493.75%-0.63 | 59.86%-0.57 | 65.94%-1.4 | 147.32%0.53 | 23.40%-0.72 | 115.69%0.16 | -36.54%-1.42 |
| Diluted earnings per share | -100.71%-2.81 | -382.93%-1.16 | 37.50%-0.45 | -493.75%-0.63 | 59.86%-0.57 | 65.94%-1.4 | 136.61%0.41 | 23.40%-0.72 | 115.69%0.16 | -36.54%-1.42 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg